ImmuCell Corporation Other Current Assets
ImmuCell Corporation (ICCC) had Other Current Assets of $57.66 thousand as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-04-01
- 2023-12-31: Other Assets, Current $57.66K.
- 2022-12-31: Other Assets, Current $76.63K.
| Period end | Other Assets, Current |
|---|---|
| 2023-12-31 | $57.66K 10-K · filed 2024-04-01 |
| 2022-12-31 | $76.63K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |